Home
Conditions
Mycosis Fungoides

Clinical trial condition

Mycosis Fungoides

Explore clinical trials studying Mycosis Fungoides. Study availability and eligibility vary by location and protocol.

308 public trials 29 recruiting studies

Refine in advanced search Browse all conditions

Mycosis Fungoides trial results

Not yet recruiting

Efficacy and Safety of Brentuximab Vedotin Combined With Lisaftoclax in CD30+ Cutaneous T-cell Lymphoma (CTCL)

NCT07717580

Conditions: Cutaneous T-Cell Lymphoma/Mycosis Fungoides, Hemic and Lymphatic Diseases, Immune System Diseases, +12 more
Locations: Peking University First Hospital Beijing, Beijing Municipality, China

View Trial Details

Not yet recruiting

A Study of Topical Duvelisib in Participants With Early-stage Mycosis Fungoides

NCT07714187

Conditions: Cutaneous T-Cell Lymphoma, Hemic and Lymphatic Diseases, Immune System Diseases, +10 more
Locations: Johns Hopkins University Baltimore, Maryland, United States

View Trial Details

Not yet recruiting

Golidocitinib in Patients With Mycosis Fungoides/Sézary Syndrome and T-Cell Large Granular Lymphocytic Leukemia

NCT07682792

Conditions: Hematologic Diseases, Hemic and Lymphatic Diseases, Immune System Diseases, +17 more
Locations: Washington University School of Medicine St Louis, Missouri, United States

View Trial Details

Not yet recruiting

Efficacy and Safety of Benvitimod Cream in Cutaneous T-Cell Lymphoma

NCT07658924

Conditions: Cutaneous T-Cell Lymphoma, Hemic and Lymphatic Diseases, Immune System Diseases, +11 more
Locations: Not specified

View Trial Details

Not yet recruiting

A Study of VG712 in Patients With Mycosis Fungoides

NCT07529405

Conditions: Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +9 more
Locations: H. Lee Moffitt Cancer Center and Research Institute Tampa, Florida, United States

View Trial Details

Not yet recruiting

A Phase 1, Multicenter, Open-label, Prospective, First-in-human Dose-escalation Clinical Trial of Domain Therapeutics' Anti-CCR8 Monoclonal Antibody (DT-7012) in Patients With Relapsed or Refractory Cutaneous T-cell Lymphomas (CTCL)

NCT07213882

Conditions: Cutaneous T Cell Lymphoma (CTCL), Hemic and Lymphatic Diseases, Immune System Diseases, +11 more
Locations: Not specified

View Trial Details

Not yet recruiting

Long-term Assessment of Chlormethine Gel in Mycosis Fungoides

NCT07046663

Conditions: Cutaneous T-Cell Lymphoma/Mycosis Fungoides, Hemic and Lymphatic Diseases, Immune System Diseases, +10 more
Locations: AOU Ospedali Riuniti - Clinica di Ematologia Ancona, Italy

SC Dermatologia, ASST-Papa Giovanni XXIII, Bergamo, Italy

UO Dermatologia - IRCCS Policlinico S.Orsola-Malpighi Bologna, Italy

UO Dermatologia ASST Spedali Civili Brescia Brescia, Italy

View all 20 locations

View Trial Details

Not yet recruiting

Evaluation of the KIR3DL2 Marker in Flow Cytometry for Sézary Syndrome Diagnosis, Therapeutic Response and Residual Disease: a Prospective and Multicenter Study

NCT06651203

Conditions: Cutaneous T Cell Lymphoma, Hemic and Lymphatic Diseases, Immune System Diseases, +12 more
Locations: Not specified

View Trial Details

Not yet recruiting

TOtal Skin Electron Beam Therapy (Low-dose) for Tumor Clone Eradication in Early-stage Mycosis Fungoides

NCT05205902

Conditions: Cutaneous T Cell Lymphoma, Hemic and Lymphatic Diseases, Immune System Diseases, +10 more
Locations: Not specified

View Trial Details

Active, not recruiting

Tulmimetostat (DZR123) in Patients With Mycosis Fungoides and Sézary Syndrome

NCT05944562

Conditions: Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +11 more
Locations: Washington University School of Medicine St Louis, Missouri, United States

View Trial Details

Mycosis Fungoides

Mycosis Fungoides trial results

Related conditions